Trexquant Investment’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History

Trexquant Investment’s Portfolio PTVE Stock Details PTVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-243,521	Closed	-$4.39M	–	1973
2025 Q1	$4.39M	Buy	243,521 +207,296	+572%	+$3.69M	0.05%	559
2024 Q4	$633K	Buy	+36,225	New	+$490K	0.01%	1221
2024 Q2	–	Sell	-39,499	Closed	-$566K	–	1921
2024 Q1	$566K	Sell	39,499 -1,254	-3%	-$17.8K	0.01%	1112
2023 Q4	$559K	Sell	40,753 -21,193	-34%	-$223K	0.01%	1041
2023 Q3	$504K	Sell	61,946 -3,262	-5%	-$26.7K	0.01%	1019
2023 Q2	$494K	Buy	+65,208	New	+$498K	0.01%	1010

Trexquant Investment's PTVE Position: Q2 2025 in Review

Trexquant Investment sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q2 2025, closing a stake of 243,521 shares — an estimated $4.39M sold.

Trexquant Investment first reported a position in PTVE in Q2 2023 and held it in 6 quarters. The position peaked at $4.39M in Q1 2025. 0 funds tracked by Wall St. Rank hold PTVE as of Q2 2025.

Trexquant Investment reported no remaining Pactiv Evergreen Inc. Common stock position as of Q2 2025 after selling out during the quarter.
Trexquant Investment sold 243,521 Pactiv Evergreen Inc. Common stock shares in Q2 2025, an estimated $4.39M.
Trexquant Investment first reported a position in Pactiv Evergreen Inc. Common stock in Q2 2023 and held it in 6 quarters.
Trexquant Investment's Pactiv Evergreen Inc. Common stock position peaked at $4.39M in Q1 2025.
0 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q2 2025.

Based on Trexquant Investment's 13F filing for Q2 2025, filed 12 Aug 2025.